Efficacy, Safety And Dose Response Of Glycopyrrolate Metered Dose Inhaler (gp Mdi) Delivered Using Co-Suspension™ Delivery Technology In Patients With Intermittent Or Mild-To-Moderate Persistent Asthma

被引：0
|
作者：
Kerwin, E. M. [1 ]
Wachtel, A. [2 ]
Sher, L. [3 ]
Nyberg, J. [4 ]
Darken, P. [4 ]
Orevillo, C. [4 ]
Dorinsky, P. [5 ]
Reisner, C. [4 ]
机构：
[1] Clin Res Inst, Medford, OR USA
[2] Southern Calif Inst Resp Dis, Los Angeles, CA USA
[3] Peninsula Res Associates, Rolling Hills Estates, CA USA
[4] Pearl Therapeut Inc, Morristown, NJ USA
[5] Pearl Therapeut Inc, Durham, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3204
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial
    Kerwin, Edward
    Wachtel, Andrew
    Sher, Lawrence
    Nyberg, Jack
    Darken, Patrick
    Siddiqui, Shahid
    Duncan, Elizabeth A.
    Reisner, Colin
    Dorinsky, Paul
    RESPIRATORY MEDICINE, 2018, 139 : 39 - 47
  • [2] Efficacy And Safety Of Budesonide Delivered By Metered Dose Inhaler (mdi) Using A Novel Co-Suspension T Delivery Technology In Adults With Mild-To-Moderate Persistent Asthma - A Phase Iib Dose-Ranging Study
    Miller, S. D.
    Orevillo, C.
    Nyberg, J.
    Dorinsky, P.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD
    Fabbri, Leonardo M.
    Kerwin, Edward M.
    Spangenthal, Selwyn
    Ferguson, Gary T.
    Rodriguez-Roisin, Roberto
    Pearle, James
    Sethi, Sanjay
    Orevillo, Chad
    Darken, Patrick
    St. Rose, Earl
    Fischer, Tracy
    Golden, Michael
    Dwivedi, Sarvajna
    Reisner, Colin
    RESPIRATORY RESEARCH, 2016, 17
  • [4] Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD
    Leonardo M. Fabbri
    Edward M. Kerwin
    Selwyn Spangenthal
    Gary T. Ferguson
    Roberto Rodriguez-Roisin
    James Pearle
    Sanjay Sethi
    Chad Orevillo
    Patrick Darken
    Earl St. Rose
    Tracy Fischer
    Michael Golden
    Sarvajna Dwivedi
    Colin Reisner
    Respiratory Research, 17
  • [5] Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
    Martinez, Fernando J.
    Rabe, Klaus F.
    Ferguson, Gary T.
    Fabbri, Leonardo M.
    Rennard, Stephen
    Feldman, Gregory J.
    Sethi, Sanjay
    Spangenthal, Selwyn
    Gottschlich, Gregory M.
    Rodriguez-Roisin, Roberto
    Arora, Samir
    Siler, Thomas M.
    Siddiqui, Shahid
    Darken, Patrick
    Fischer, Tracy
    Maes, Andrea
    Golden, Michael
    Orevillo, Chad
    Reisner, Colin
    CHEST, 2017, 151 (02) : 340 - 357
  • [6] Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD
    Chen, Rongchang
    Zhong, Nanshan
    Wang, Hao-Yan
    Zhao, Li
    Mei, Xiaodong
    Qin, Zhiqiang
    Huang, Juan
    Assam, Pryseley N.
    Maes, Andrea
    Siddiqui, Shahid
    Martin, Ubaldo J.
    Reisner, Colin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 43 - 56
  • [7] EFFICACY AND SAFETY OF GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE METERED DOSE INHALER (GFF MDI) DELIVERED USING CO-SUSPENSION DELIVERY TECHNOLOGY IN CHINESE PATIENTS WITH COPD
    Zhong, Nanshan
    Chen, Rongchang
    Wang, Hao-Yan
    Zhao, Li
    Mei, Xiaodong
    Qin, Zhiqiang
    Assam, Pryseley N.
    Maes, Andrea
    Martin, Ubaldo J.
    Reisner, Colin
    RESPIROLOGY, 2018, 23 : 81 - 81
  • [8] Cardiovascular safety profile of a fixed-dose combination of glycopyrrolate and formoterol fumarate delivered via metered dose inhaler using co-suspension delivery technology
    Ferguson, Gary T.
    Reisner, Colin
    Pearle, James
    DePetrillo, Paolo
    Maes, Andrea
    Martin, Ubaldo J.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 49 : 67 - 74
  • [9] Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease
    Gon, Yasuhiro
    Nishi, Koichi
    Sato, Kazuhiro
    Maes, Andrea
    Siddiqui, Shahid
    Hayashi, Nobuya
    Hirata, Hajime
    Martin, Ubaldo J.
    Reisner, Colin
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 135 - 144
  • [10] Efficacy and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (GFF MDI) delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe COPD
    Gon, Yasuhiro
    Nishi, Koichi
    Sato, Kazuhiro
    Maes, Andrea
    Siddiqui, Shahid
    Hayashi, Nobuya
    Hirata, Hajime
    Reisner, Colin
    Martin, Ubaldo J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345